CELLCEPT (mycophenolate mofetil) Coupons, Discounts & Cost

CELLCEPT (mycophenolate mofetil) Coupons, Discounts & Cost
GSMeds.to ( visit store )
1 0
Comments Off
Want to say something? Add Comment 

CellCept (mycophenolate mofetil) Coupons, Discounts & Cost

CellCept (mycophenolate mofetil) is an immunosuppressive agent, which is used primarily in the prevention of rejection of transplant organs. One way to save money on the CellCept (mycophenolate mofetil) retail cost regardless of income and insurance status is to use CellCept (mycophenolate mofetil) coupons or discount cards from RXCoupons. Use this CellCept (mycophenolate mofetil) coupon at this online pharmacy and receive up to 75% off the sale price.

CellCept (mycophenolate mofetil) general information

CellCept (mycophenolate mofetil) is an immunosuppressive agent, which is used primarily in the prevention of rejection of transplant organs. The drug is prescribed for the prevention of organ rejection in patients after transplantation of kidney, heart, liver (as part of combination therapy with cyclosporine and corticosteroids). Mycophenolate mofetil is the basis of immunosuppressive therapy following organ transplantation. CellCept reduces the incidence of late renal transplant failure and increases the survival of patients after kidney transplantation.

This drug can be used for a long time. The usual dose of CellCept is 500 mg several times a day. The average allowable dosage should not exceed 2-3g.

As for side effects, in most cases patients may experience nausea, headaches and gastrointestinal disorders. Usually these symptoms disappear when you reduce the dose. But if the improvement does not occur, you should stop taking this medication or choose another therapy.

All the manipulations associated with CellCept treatment, dosage adjustment or cancellation of the preparation should be done only under the supervision of a specialist.

CellCept (mycophenolate mofetil) indications for use

The drug is prescribed as a part of complex treatment with corticosteroids and cyclosporine for prophylaxis of acute organ rejection in patients after renal transplantation. It helps improve the survival rate of patients who underwent heart or liver transplantation.

CellCept (mycophenolate mofetil) contraindications

CellCept (mycophenolate mofetil) is not recommended:
– For patients with hypersensitivity to mycophenolate mofetil;
– During lactation or pregnancy.

Caution is required in the presence of acute gastrointestinal diseases.

CellCept (mycophenolate mofetil) side effects

The main side effects that can accompany CellCept (mycophenolate mofetil) therapy are: diarrhea, sepsis, leucopenia, vomiting, opportunistic infections and other disorders.

CellCept (mycophenolate mofetil) dosing regimen

This drug can be administered in a variety of cases in order to prevent organ rejections. The appropriate dosage is determined depending on the indication.

Prevention of kidney transplant rejection: the drug is administered in a dosage of 1 g twice daily, but not more than 2 g per day.

In order to prevent rejection of the heart or liver transplant, the daily dose is of 1.5 g twice daily.

Treatment of refractory acute kidney transplant rejection: the drug is administered in a dosage of 1.5 g twice daily. It is recommended to take CellCept as soon as possible.

Special indications: patients with severe chronic renal failure should not the doses higher than 2 g a day.

In case of neutropenia, patients should reduce the dose or even stop taking the drug.

The dose for elderly people should be 1 g twice daily.

In any case, the therapy regimen and other conditions should be determined by your physician.

CellCept (mycophenolate mofetil) overdose

CellCept (mycophenolate mofetil) overdose symptoms may include: immunosuppression, increased sensitivity to infections and bone marrow suppression.

Treatment: patients should stop the therapy or reduce the dose of the drug.

CellCept (mycophenolate mofetil) interaction

CellCept (mycophenolate mofetil) may increase the concentration of acyclovir in plasma (in patients with renal failure).

Antacids (that contain magnesium or aluminum hydroxide) can reduce the absorption of mycophenolate mofetil.

Simultaneous treatment with tacrolimus may lead to changes in mycophenolic acid concentration.

It is not recommended to use live vaccines during treatment with CellCept, since it can lead to a significant reduction in antibody production.

CellCept (mycophenolate mofetil) storage conditions

Patients should store this drug is dry, dark and cool place, inaccessible to children.

Comments are closed.